Home > E. Pathology by systems > Urinary system > Kidneys > renal tubular dysgenesis

renal tubular dysgenesis

Thursday 19 February 2004

Renal tubular dysgenesis is a rare condition defined by the histopathologic findings of a paucity or absence of proximal tubules in the kidney.

Clinical synopsis

- oligohydramnios with Potter sequence (oligohydramnios sequence)
- prematurity
- renal size and gross morphology generally normal

Microscopical synopsis

- absence of proximal tubular differentiation
- all tubules are EMA+
- paucity of proximal tubules
- crowding of glomeruli
- renal tubules are short, lack convolutions and connections to the collecting tree
- reduced number of papillary ductal pores

Etiology

- familial renal tubular dysgenesis (autosomal recessive inheritance) (#12908573#): homozygous or compound heterozygous mutations in the genes encoding

    • renin (REN)
    • angiotensinogen (AGT)
    • angiotensin converting enzyme (ACE)
    • angiotensin II receptor type 1 (AGTR1)

- sporadic renal tubular dysgenesis

  • in utero exposure to non-steroidal anti-inflammatory agents (NSAIDs fetopathy)
    • in utero exposure to piroxicam
  • in utero exposure to angiotensin-converting enzyme inhibitor (ACEIs fetopathy) (#12657763#)
  • intrauterine fetal ischemia
    • twin-to-twin transfusion syndrome (#9841703#)
    • acardia
  • unilateral renal tubular dysgenesis
    • fetal renal artery stenosis
    • fetal renal vein thrombosis
  • endstage renal disease of various causes
  • other associations
    • neonatal hemochromatosis (#14677054#, #9688768#)
    • hypoplastic calvaria
    • trisomy 21 (#15018458#, #14564541#)
    • severe cranium hypoplasia (#15043673#)
    • medullary ray nodules (#12644933#)

References

- Benini D, Fanos V, Cuzzolin L, Tato L. In utero exposure to nonsteroidal anti-inflammatory drugs: neonatal renal failure. Pediatr Nephrol. 2004 Feb;19(2):232-4. PMID: #14648334#

- Lasaitiene D, Chen Y, Guron G, Marcussen N, Tarkowski A, Telemo E, Friberg P. Perturbed medullary tubulogenesis in neonatal rat exposed to renin-angiotensin system inhibition. Nephrol Dial Transplant. 2003 Dec;18(12):2534-41. PMID: #14605275#

- Kaplan BS, Restaino I, Raval DS, Gottlieb RP, Bernstein J. Renal failure in the neonate associated with in utero exposure to non-steroidal anti-inflammatory agents. Pediatr Nephrol. 1994 Dec;8(6):700-4. PMID: #7696108#

- Jain V, Beneck D. Renal tubular dysgenesis in an hydropic fetus with trisomy 21: a case report with literature review. Pediatr Dev Pathol. 2003 Nov-Dec;6(6):568-72. PMID: #15018458#

- Kumral A, Duman N, Gulcan H, Sarioglu S, Tuncer C, Ozkan H. Renal tubular dysgenesis and multiple intestinal perforation. Pediatr Dev Pathol. 2003 Jan-Feb;6(1):96-8. Epub 2002 Nov 27. PMID: #12447649#

- Moldavsky M. Lysozyme immunostaining in renal tubular dysgenesis. Pediatr Dev Pathol. 2000 Mar-Apr;3(2):200-1. No abstract available. PMID: #10679040#

- Oberg KC, Pestaner JP, Bielamowicz L, Hawkins EP. Renal tubular dysgenesis in twin-twin transfusion syndrome. Pediatr Dev Pathol. 1999 Jan-Feb;2(1):25-32. PMID: #9841703#

- Johal JS, Thorp JW, Oyer CE. Neonatal hemochromatosis, renal tubular dysgenesis, and hypocalvaria in a neonate. Pediatr Dev Pathol. 1998 Sep-Oct;1(5):433-7. PMID: #9688768#

Portfolio

  • Renal tubular dysgenesis
  • EMA immunolabelling in renal tubular dysgenesis
  • Renal tubular dysgenesis
  • Renal tubular dysgenesis
  • Renal tubular dysgenesis
  • Renal tubular dysgenesis
  • Renal tubular dysgenesis
  • Renal tubular dysgenesis
  • Renal tubular dysgenesis
  • Renal tubular dysgenesis
  • Renal tubular dysgenesis